Cryo-EM as a powerful tool for drug discovery: recent structural based studies of SARS-CoV-2

• Main Authors: Han-ul Kim, Hyun Suk Jung
• Format: Article
• Language: English
• Published: SpringerOpen 2021-09-01
• Series: Applied Microscopy
• Subjects: Transmission electron microscopy; Cryo-electron microscopy; Structure-based drug design; Fragment-based drug discovery; Severe acute respiratory syndrome coronavirus 2
• Online Access: https://doi.org/10.1186/s42649-021-00062-x

Abstract The novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has arisen as a global pandemic affecting the respiratory system showing acute respiratory distress syndrome (ARDS). However, there is no targeted therapeutic agent yet and due to the growing cases of infections and the rising death tolls, discovery of the possible drug is the need of the hour. In general, the study for discovering therapeutic agent for SARS-CoV-2 is largely focused on large-scale screening with fragment-based drug discovery (FBDD). With the recent advancement in cryo-electron microscopy (Cryo-EM), it has become one of the widely used tools in structural biology. It is effective in investigating the structure of numerous proteins in high-resolution and also had an intense influence on drug discovery, determining the binding reaction and regulation of known drugs as well as leading the design and development of new drug candidates. Here, we review the application of cryo-EM in a structure-based drug design (SBDD) and in silico screening of the recently acquired FBDD in SARS-CoV-2. Such insights will help deliver better understanding in the procurement of the effective remedial solution for this pandemic.